Scholarly Index
Alfredo J. Lucendo
Hospital General de Tomelloso; 17,442 total citations; 430 total publications; best world rank #19
Hospital General de Tomelloso
17,442Total citations
430Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Eosinophilic Esophagitis | Lifetime | 153 | ES 2 | 99.06 |
| Eosinophilic Disorders and Syndromes | Lifetime | 152 | ES 3 | 98.66 |
| Esophageal and GI Pathology | Lifetime | 495 | ES 4 | 98.28 |
| IL-33, ST2, and ILC Pathways | Lifetime | 252 | ES 3 | 97.53 |
| Microscopic Colitis | Lifetime | 408 | ES 14 | 97.93 |
| Inflammatory Bowel Disease | Lifetime | 677 | ES 25 | 97.25 |
| Celiac Disease Research and Management | Lifetime | 406 | ES 14 | 95.00 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 230 | ES 16 | 88.33 |
| Eosinophilic Esophagitis | 2021-2025 | 19 | ES 1 | 99.33 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 24 | ES 2 | 98.90 |
| Esophageal and GI Pathology | 2021-2025 | 432 | ES 4 | 93.84 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 157 | ES 1 | 91.37 |
| Gastroesophageal reflux and treatments | 2021-2025 | 207 | ES 3 | 92.60 |
| Inflammatory Bowel Disease | 2021-2025 | 714 | ES 35 | 92.51 |
| Liver Diseases and Immunity | 2021-2025 | 684 | ES 30 | 81.08 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 894 | ES 31 | 73.76 |
| Veterinary medicine and infectious diseases | 2021-2025 | 628 | ES 20 | 50.08 |